BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Tuesday, January 13, 2026
Home » Topics » Analysis and data insight, BioWorld MedTech

Analysis and data insight, BioWorld MedTech
Analysis and data insight, BioWorld MedTech RSS Feed RSS

Med-tech gainers and losers for Dec. 18-22, 2023

Dec. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Dec. 11-15, 2023

Dec. 18, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
medtech deals
Med-tech deals November 2023

November sees $441M in deals, cumulative value up 34% YOY

Dec. 15, 2023
By Amanda Lanier

Total med-tech deal value through November is up 34.42% over the same period last year and is also higher than every comparable period from 2019-2022. Conversely, med-tech M&A value experienced a decline of 64.07% compared to the first 11 months of 2022.


Read More
Dollar symbol with arrow graph

Med-tech gainers and losers for Dec. 4-8, 2023

Dec. 11, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Stock chart, red down arrow
Med-tech financings November 2023

Med-tech financings mark YOY decline, November sees more than $1B raised

Dec. 8, 2023
By Amanda Lanier
Med-tech financings surpassed $1 billion again in November, with transactions totalling $1.02 billion for the month. Though a decline from the $1.23 billion raised in October, the value is up from September’s $645.75 million.
Read More

Med-tech gainers and losers for Nov. 27-Dec. 1, 2023

Dec. 4, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 20-24, 2023

Nov. 27, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 13-17, 2023

Nov. 20, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More

Med-tech gainers and losers for Nov. 6-10, 2023

Nov. 13, 2023
The top 10 med-tech stock gainers and losers for the week.
Read More
Med-tech deals October 2023

Med-tech M&As continue decline while deal value soars nearly 50% YOY

Nov. 10, 2023
By Amanda Lanier
While med-tech deals were well below average the past two months, cumulative values are up 47.67% over the same period last year. Through October, the total worth of med-tech deals reached $9.97 billion, rising from $6.75 billion in the corresponding period in 2022.
Read More
Previous 1 2 … 17 18 19 20 21 22 23 24 25 … 52 53 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Jan 12, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for Jan. 12, 2026.
  • 3D rendering of antibody drug conjugated with cytotoxic payload

    ADCs’ breakout 2025 and their still-unfinished potential

    BioWorld
    Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
  • Icons representing scientific research

    Science in 2025: the best of the rest

    BioWorld Science
    A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
  • Lung cancer illustration

    LINC01116 has prognostic value in lung cancer, study shows

    BioWorld MedTech
    Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • NME Digest
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing